Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-18-015655
Filing Date
2018-11-14
Accepted
2018-11-14 10:20:45
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT NO. 2 f424b3111318_adialpharma.htm 424B3 678645
2 GRAPHIC image_001.jpg GRAPHIC 21201
3 GRAPHIC image_002.jpg GRAPHIC 71035
  Complete submission text file 0001213900-18-015655.txt   807167
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

EIN.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-220368 | Film No.: 181181105
SIC: 2834 Pharmaceutical Preparations